16-2092941-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001009944.3(PKD1):c.11156+13G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,612,910 control chromosomes in the GnomAD database, including 153 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001009944.3 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.11156+13G>A | intron_variant | Intron 38 of 45 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0102 AC: 1552AN: 152206Hom.: 8 Cov.: 33
GnomAD3 exomes AF: 0.0107 AC: 2672AN: 250636Hom.: 30 AF XY: 0.0103 AC XY: 1395AN XY: 135774
GnomAD4 exome AF: 0.0124 AC: 18047AN: 1460586Hom.: 145 Cov.: 32 AF XY: 0.0121 AC XY: 8756AN XY: 726580
GnomAD4 genome AF: 0.0102 AC: 1553AN: 152324Hom.: 8 Cov.: 33 AF XY: 0.0104 AC XY: 775AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:3
- -
- -
- -
Polycystic kidney disease, adult type Benign:1
- -
Autosomal dominant polycystic kidney disease Benign:1
The PKD1 c.11156+13G>A variant was identified in 10 of 462 proband chromosomes (frequency: 0.022) from individuals or families with ADPKD (Aguiari 2000, Perrichot 1999, Rossetti 2002). The variant was also identified in dbSNP (ID: rs142616270), as “NA”, ADPKD Mutation Database (as likely neutral), in the 1000 Genomes Project in 23 of 5000 chromosomes (frequency: 0.005), NHLBI GO Exome Sequencing Project in 99 of 8600 European American(freq. 0.01) and in 12 of 4396 African American alleles (freq. 0.003), the Exome Aggregation Consortium database (March 14, 2016) in 1179 (10 homozygous) of 120304 chromosomes (freq. 0.01) in the following populations: European in 869 of 65786 chromosomes (freq. 0.01), Finnish in 177 of 6614 chromosomes (freq. 0.03), Latino in 76 of 11556 chromosomes (freq. 0.006), African in 30 of 10312 chromosomes (freq. 0.003), South Asian in 9 of 16510 chromosomes (freq. 0.0005), Other in 18 of 896 chromosomes (freq. 0.02), increasing the likelihood this could be a low frequency benign variant. The variant occurs outside of the splicing consensus sequence and 3 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. However, this information is not predictive enough to assume pathogenicity. In addition, one population study classified the variant as polymorphism since the affected mother carried this nucleotide variation but one of her affected daughters did not share this abnormality (Perrichot 1999). The identification of this variant in an individual by our lab with a co-occurring pathogenic variant (PKD1, c.1583A>G) increases the likelihood this variant does not have clinical significance. In summary, based on the above information, this variant meets our laboratory's criteria to be classified as benign. -
not provided Benign:1
PKD1: BS1, BS2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at